Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Cryoablation for the Treatment of Breast Cancer: A Prospective Study of Clinical Effectiveness, Safety, and CEM-Based Imaging Surveillance

NCT07775014 is registered in ClinicalTrials.gov with Ospedale Cottolengo as lead sponsor.

NCT NCT07775014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07775014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Cryoablation for the Treatment of Breast Cancer: A Prospective Study of Clinical Effectiveness, Safety, and CEM-Based Imaging Surveillance
Lead sponsor
Ospedale Cottolengo
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
November 30, 2030
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer - infiltrating ductal carcinoma